Test how reliable a liver scan is in chronic hepatitis
Part of Digestive system, Infections clinical trials.
This study checks whether a “liver stiffness” scan (called transient elastography) gives consistent, dependable results in adults with long-term viral hepatitis. It may help improve how doctors monitor liver changes over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have long-term (chronic) viral hepatitis
- You are an adult
- You are receiving care at the infectious diseases departments in Malmö, Lund, or Helsingborg
- You can sign the study consent form
- You are not suspected to be pregnant or confirmed to be pregnant
- You can speak Swedish
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks people who are at higher risk for liver scarring by using noninvasive tests. If those tests suggest significant scarring, the study may consider further testing, but not everyone will need a biopsy.
This study compares a handheld scanner (elastography device) with a standard scanner (iLivTouch) to measure liver stiffness in people with chronic hepatitis B, fatty liver disease, or related cirrhosis. The goal is to see how well the handheld device works, which could make liver testing easier and more accessible.
This study compares two non-invasive ultrasound methods (EUS-SWQ and FibroScan) with liver biopsy to see how well they detect liver scarring in patients with chronic liver disease. The goal is to improve how doctors diagnose and monitor liver damage from conditions like hepatitis B and fatty liver disease.
This trial looks for better ways to detect liver scarring (fibrosis) in people with long-term liver disease. It may help find problems earlier.
This trial tests a new wearable patch that uses ultrasound to measure liver stiffness, which can help diagnose scarring. It may be an option if you already need or recently had a FibroScan for chronic liver disease.
This study looks at how well noninvasive tests (tests that don’t require surgery, like scans and blood-based measurements) can diagnose chronic liver disease in people with certain liver conditions. It may help doctors choose better, less invasive ways to identify the type and stage of liver problems.
Hear when a new Chronic Viral Hepatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.